Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SARS-CoV-2 spike} (SARS-CoV-2 S-pMHC)
- Target
- SARS-CoV-2 S-pMHC
01
Overview
- Other names
- SARS-CoV-2 spike antigen-HLA complexSpike peptide-MHCS-pMHCSARS-CoV-2 spike epitope-HLA complex
02
Biological functions
Antigen presentationImmune responseT-cell activationCellular immunity
03
Biomarkers
HLA-A*02:01 (Saini et al., 2021)HLA-B*07:02 (Grifoni et al., 2020)Peptide-MHC multimer bindingInterferon-gamma release assay (IGRA)
Beyond the preview
Go deeper on SARS-CoV-2 spike} (SARS-CoV-2 S-pMHC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SARS-CoV-2 spike} (SARS-CoV-2 S-pMHC).